Zotou Anastasia, Siampalioti Athina, Tagari Panagiota, Paridis Leonidas, Kalfarentzos Fotis, Filos Kriton S
Department of Anesthesiology and Critical Care Medicine, University Hospital of Patras, Rion, Patras, 26504, Greece,
Obes Surg. 2014 Dec;24(12):2099-108. doi: 10.1007/s11695-014-1305-z.
Insufficient data exist regarding postoperative thoracic epidural analgesia for morbidly obese patients undergoing open bariatric surgery. This study evaluated the effectiveness of morphine loading in a postoperative thoracic epidural analgesic regimen of patient-controlled epidural analgesia (PCEA) with levobupivacaine combined with continuously administered epidural morphine in this patient group.
In this prospective randomized controlled trial, 48 superobese patients (body mass index of ≥ 50 kg/m(2)) undergoing open bariatric surgery were randomly allocated to three groups of 16 patients each. Postoperatively, all groups received a continuous epidural morphine infusion of 0.2 mg/h with 0.1 % levobupivacaine via PCEA. Group A did not receive intraoperative epidural morphine loading, while groups B and C received an intraoperative 1- and 2-mg morphine bolus, respectively. Levobupivacaine consumption via PCEA (primary outcome), pain scores at rest and on cough, the time to return of bowel function and ambulation, and arterial blood gas levels (secondary outcomes) were recorded.
The increase in perioperative morphine administration (groups B and C) led to a significantly prolonged return to normal bowel function and delayed ambulation (P<0.05 to 0.01, respectively), without an improvement in postoperative analgesia or a reduction in local anesthetic consumption. Although the prevalence of obstructive sleep apnea (OSA) was high in all groups, no respiratory depression was observed.
Thoracic PCEA with 0.1 % levobupivacaine combined with continuous epidural morphine administration of 0.2 mg/h without morphine loading is an effective postoperative analgesic regimen that provides adequate pain control, early ambulation, and early return of bowel function in superobese patients, particularly those with OSA.
关于接受开放式减肥手术的病态肥胖患者术后胸段硬膜外镇痛的数据不足。本研究评估了在该患者群体中,左旋布比卡因患者自控硬膜外镇痛(PCEA)联合持续硬膜外注射吗啡的术后胸段硬膜外镇痛方案中,吗啡负荷量的有效性。
在这项前瞻性随机对照试验中,48例接受开放式减肥手术的超级肥胖患者(体重指数≥50 kg/m²)被随机分为三组,每组16例。术后,所有组均通过PCEA接受0.2 mg/h的持续硬膜外吗啡输注及0.1%左旋布比卡因。A组术中未接受硬膜外吗啡负荷量,而B组和C组分别接受术中1 mg和2 mg的吗啡推注。记录通过PCEA的左旋布比卡因消耗量(主要结局)、静息和咳嗽时的疼痛评分、肠功能恢复和下床活动时间以及动脉血气水平(次要结局)。
围手术期吗啡给药量增加(B组和C组)导致肠功能恢复正常的时间显著延长且下床活动延迟(分别为P<0.05至0.01),术后镇痛无改善,局部麻醉药消耗量也未减少。尽管所有组中阻塞性睡眠呼吸暂停(OSA)的患病率都很高,但未观察到呼吸抑制。
0.1%左旋布比卡因联合0.2 mg/h持续硬膜外吗啡给药且无吗啡负荷量的胸段PCEA是一种有效的术后镇痛方案,可为超级肥胖患者,尤其是患有OSA的患者提供充分的疼痛控制、早期下床活动和肠功能早期恢复。